| __timestamp | Ascendis Pharma A/S | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19698000 | 7459000 |
| Thursday, January 1, 2015 | 40528000 | 11831000 |
| Friday, January 1, 2016 | 66022000 | 25705000 |
| Sunday, January 1, 2017 | 99589000 | 46181000 |
| Monday, January 1, 2018 | 140281000 | 59497000 |
| Tuesday, January 1, 2019 | 191621000 | 65003000 |
| Wednesday, January 1, 2020 | 260904000 | 74506000 |
| Friday, January 1, 2021 | 295867000 | 126006000 |
| Saturday, January 1, 2022 | 379624000 | 126215000 |
| Sunday, January 1, 2023 | 413454000 | 120161000 |
| Monday, January 1, 2024 | 307004000 |
Unlocking the unknown
In the dynamic world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Ascendis Pharma A/S and Protagonist Therapeutics, Inc. have been at the forefront of this race since 2014. Over the past decade, Ascendis Pharma has consistently outpaced Protagonist Therapeutics, with its R&D expenses growing by over 2,000% from 2014 to 2023. In contrast, Protagonist Therapeutics saw a more modest increase of approximately 1,500% during the same period. By 2023, Ascendis Pharma's R&D spending was nearly 3.5 times that of Protagonist Therapeutics. This significant investment underscores Ascendis Pharma's aggressive pursuit of innovation, positioning it as a leader in the biotech sector. As these companies continue to push the boundaries of medical science, their R&D investments will be pivotal in shaping the future of healthcare.
Sanofi vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Ascendis Pharma A/S
R&D Insights: How Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Ascendis Pharma A/S vs Verona Pharma plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Comparing Innovation Spending: Ascendis Pharma A/S and Mesoblast Limited
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Expenses Breakdown: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending